Dingshi Biomedical Technology
Specialized medical devices for minimally invasive surgery.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY20.0m | Series A | |
| Total Funding | 000k | ||
Dingshi Biomedical Technology, headquartered in Ningbo, China, is a company focused on the development and production of medical devices for the biomedical sector. The company specializes in creating solutions for minimally invasive surgical procedures, aiming to enhance the precision and effectiveness of medical treatments.
Established in September 2019, the firm operates on a business-to-business model, supplying its specialized equipment to healthcare providers and surgical centers. In March 2025, Dingshi Biomedical secured CNY 20 million in a Series A funding round from investors including TriWise Capital and Ovctek China, which brought its total funding to approximately €2.5 million.
The company's product line includes a range of surgical instruments and systems designed to support complex operations. These tools are engineered to provide surgeons with greater control and visibility, contributing to better patient outcomes and potentially shorter recovery times. The business generates revenue through the sale of these devices within the competitive medical technology market.
Keywords: minimally invasive surgery, medical devices, surgical instruments, biomedical technology, medtech, surgical solutions, healthcare technology, Ningbo, Series A, surgical equipment